View more Leadership Team
Dr Anna Golebiewska
WG2 Leader
Area of Research
PRECLINICAL MODELS (Theme-2). Development of more accurate genetically engineered mouse models (GEMMs), and patient-derived orthotopic xenografts models (PDOXs), as well as 3D Systems (neurosphere, organoids and bioprinting) should contribute to a better understanding of brain tumour mechanisms.
Biography
It is estimated that 3.24 million new cancer cases and 1.66 million cancer deaths will be registered across Europe in 2024, and 40,800 of these deaths are from brain and central nervous system (CNS) cancers. Despite extensive efforts in molecular biology research, advances in biomedical engineering, artificial intelligence (AI), and big data science, brain tumours remain among the deadliest forms of cancer…
Projects & Grants
Preclinical Models